Caren van Roekel

238 Chapter 9 TABLE 1. Patient and treatment characteristics Characteristic n or median + range All included patients(n=28) Treated population (n=21) Gender Male 17 13 Female 11 8 Age (y) 60 (37-83) 63 (45-83) WHO performance score 0 18 16 1 9 5 2 1 0 Primary tumor location Left 21 14 Right 7 7 Previous therapy Locoregional (liver) 3 3 Metastasectomy 3 3 Systemic 28 21 5-FU 9 6 Bevacizumab 24 18 Capecitabine 24 19 Cetuximab 2 2 Folinic acid 9 6 Irinotecan 19 14 Oxaliplatin 26 19 Panitumumab 9 7 Regorafenib 1 1 TAS-102 3 1 Trifluridine+tipiracil 1 0 Extrahepatic disease before treatment Lymph node 12 9 Lung 9 7 Ovaries 1 0 Peritoneum 1 0 No 11 9